FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Unichem Pharmaceuticals Clonidine Hydrochloride Tablets Recall

Clonidine Hydrochloride Tablets, USP 0

UNICHEM PHARMACEUTICALS USA INC · East Brunswick, NJ

Risk level
Class III
Reported by FDA
Jun 17, 2020
Recall ID
D-1291-2020
Check your lot numberHow we source this data

Summary

Unichem Pharmaceuticals recalled Clonidine Hydrochloride Tablets starting May 26, 2020. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1291-2020 on Jun 17, 2020. Reason: Failed Impurities/Degradation Specifications: potential migration of benzophenone at very low level into the product from container. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications: potential migration of benzophenone at very low level into the product from container.

Product description

Clonidine Hydrochloride Tablets, USP 0.1 mg 100-count bottles, Rx only, Manufactured by: Unichem Laboratories LTD. Pilerne Ind. Estate, Pilerne, Bardez, Goa 403 511, India Manufactured for : Unichem Pharmaceuticals (USA), Inc. East Brunswick, NJ 08816, NDC 29300-135-01

Lot numbers, UPCs & expiration codes

Lot #: GCLL19034, GCLL19035, GCLL19036, Exp. 4/30/2021; GCLL19044, Exp. 6/30/2021

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1291-2020
Classification
Class III
Status
Terminated
Recall initiated
May 26, 2020
FDA report date
Jun 17, 2020
Quantity
190,992 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
UNICHEM PHARMACEUTICALS USA INC

Original FDA data

Every field from FDA enforcement report D-1291-2020, exactly as published.

Show all FDA fields
City
East Brunswick
State
NJ
Status
Terminated
Country
United States
Event ID
85764
Address
1 Tower Center Blvd Ste 2200
Code information
Lot #: GCLL19034, GCLL19035, GCLL19036, Exp. 4/30/2021; GCLL19044, Exp. 6/30/2021
Postal code
08816-1145
Report date
Jun 17, 2020
Product type
Drugs
Recall number
D-1291-2020
Classification
Class III
Recalling firm
UNICHEM PHARMACEUTICALS USA INC
Product quantity
190,992 bottles
Termination date
Jan 8, 2021
Reason for recall
Failed Impurities/Degradation Specifications: potential migration of benzophenone at very low level into the product from container.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Clonidine Hydrochloride Tablets, USP 0.1 mg 100-count bottles, Rx only, Manufactured by: Unichem Laboratories LTD. Pilerne Ind. Estate, Pilerne, Bardez, Goa 403 511, India Manufactured for : Unichem Pharmaceuticals (USA), Inc. East Brunswick, NJ 08816, NDC 29300-135-01
Distribution pattern
Nationwide within the United States
Recall initiation date
May 26, 2020
Initial firm notification
Letter
Center classification date
Jun 8, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1291-2020, published Jun 17, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls